PI3Ks And BTK Inhibitors Will Still Be Economic Drivers Until 2016
Saturday, February 16, 2013 - 04:30
in Health & Medicine
Heightened regulation, increased lawsuits and a resulting lack of venture capital has meant the western pharmaceutical industry faces a looming crisis but companies outside America and Europe may pick up the slack - new targets/drugs remain an evergreen medical idea elsewhere, especially to address the unmet need of drug resistance in the treatment of cancer. read more